Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer

NCT04304209 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

195

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Stage II
Colorectal Cancer Stage III

Interventions

DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Sintilimab
RADIATION: radiotherapy
PROCEDURE: total mesorectal excision
OTHER: Watch and wait

Sponsor

Sun Yat-sen University